[Radiotherapy of Oropharyngeal Carcinoma (author's transl)].
The malignant oropharyngeal tumors form an heterogenous entity in therapy and prognosis. The surgeon and the radiotherapist must coordinate their treatment possibilities according to histology ane localization to a combined modality pretherapeutically to obtain good results. The advantages of preoperative radiotherapy can be greater than of postoperative irradiation. The side effects and sequelae of radiotherapy are not seldom considerable. The 5 year-survival rates start with 26% for tumors of the posterior wall and reach 67% at the soft palate.
D006801:Humans; D008223:Lymphoma / Q000532:radiotherapy; D009062:Mouth Neoplasms / Q000532:radiotherapy*; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011379:Prognosis
Zur Strahlentherapie der Oropharynxkarzinome.